Evidence map›Paper›PMID 31869661›Full record

ArticleJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology2020

Performance evaluation of the Panther Fusion® respiratory tract panel.

Jolanda J C Voermans, Daphne G J C Mulders, Suzan D Pas, Marion P G Koopmans, Annemiek A van der Eijk, Richard Molenkamp

Abstract readEvaluation Study
In one paragraph

Article in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Agnostic Sequencing for Detection of Viral Pathogens.Clinical microbiology reviews · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jolanda J C VoermansDepartment of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands. Electronic address: j.voermans@erasmusmc.nl.
Daphne G J C MuldersDepartment of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
Suzan D PasDepartment of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
Marion P G KoopmansDepartment of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
Annemiek A van der EijkDepartment of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
Richard MolenkampDepartment of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRespiratory tract infections are among the most common infections during winter season. Rapid diagnostics is required for clinical decision making regarding isolation of patients and appropriate therapy.

objectivesThe aim of this study was to evaluate the analytical and clinical performance characteristics of the Panther Fusion® respiratory panel using published laboratory-developed real-time PCR assays (LDT). STUDY

designAnalytical sensitivity of Panther Fusion® Flu A/B/RSV was assessed by testing dilutions of cell culture isolates. Clinical performance assessment included the complete Panther Fusion® respiratory panel (Flu-A/B/RSV, PIV 1-4 and AdV/hMPV/RV) and consisted of a retrospective and a prospective study-arm. The retrospective evaluation included 201, stored (-80 °C) samples collected between February 2006 and January 2017. Prospective evaluation was performed on 1045 unselected pretreated respiratory tract samples from patients presented to our hospital between November 2017 and May 2018.

resultsAnalytical sensitivity was generally slightly lower for the Panther Fusion® assays. Clinical specificity and sensitivity was between 96 %-100 % and 71.9 %-100 %, respectively. Discrepant results were found in 146 samples of which 88 samples tested LDT positive / Panther Fusion® negative and 58 samples were LDT negative / Panther Fusion® positive. A total of ten discrepant samples with Ct-values <30 were sequenced to confirm the presence of 7 RV-C not-detected by LDT and 1 RV-A and 2 ADV-2 not detected by Panther Fusion®.

conclusionsThe Panther Fusion® provides a random-access system with continuous loading and much shorter sample-to-answer times compared to LDT, albeit with a slightly less clinical sensitivity compared to the LDT.

Indexed as

HumansMolecular Diagnostic TechniquesProspective StudiesReal-Time Polymerase Chain ReactionRespiratory Tract InfectionsRetrospective StudiesSensitivity and SpecificityVirus DiseasesPanther fusion®Rapid diagnosticsReal-time PCRRespiratory virusesSample-to-answer

Identifiers

PMID31869661
PMCPMC7172494

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.